Incluzn Lifesciences Private Limited
Founded in 2018 and headquartered in Madhya Pradesh, India.
2018 | Indore, Madhya Pradesh (India) | Active
Incluzn Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 550.12%
- Profit Growth 172.27%
- Ebitda 917.72%
- Net Worth 14.78%
- Total Assets 284.38%
About Incluzn Lifesciences
Incluzn Lifesciences Private Limited (ILPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 October 2018 (Six years and four months 26 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Uday Suhane and Shikha Suhane serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909MP2018PTC046797
- Company No.
046797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Trading
Other Industry
Who are the key members and board of directors at Incluzn Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Suhane  | Director | 05-Oct-2018 | Current |
| Shikha Suhane | Director | 05-Oct-2018 | Current |
Financial Performance of Incluzn Lifesciences.
Incluzn Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 550.12% increase. The company also saw a substantial improvement in profitability, with a 172.27% increase in profit. The company's net worth Soared by an impressive increase of 14.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incluzn Lifesciences?
Unlock access to Incluzn Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Incluzn Lifesciences?
Unlock and access historical data on people associated with Incluzn Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incluzn Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incluzn Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.